Sector consensus Tarsus Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-16 EDT			5-day change	1st Jan Change
77.64 ^USD	-0.75%		-6.20%	-5.18%

09-09	Tarsus Pharmaceuticals Insider Sold Shares Worth $387,940, According to a Recent SEC Filing	MT
09-09	Tarsus Pharmaceuticals Insider Sold Shares Worth $1,220,885, According to a Recent SEC Filing	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
TARSUS PHARMACEUTICALS, INC.			96.12	+22.87%	8
REGENERON PHARMACEUTICALS, INC.			849.32	+9.72%	27
CSL LIMITED			123.59	-0.55%	17
MODERNA, INC.			119.56	-16.84%	18
SAMSUNG BIOLOGICS CO.,LTD.			1,967,520	+39.34%	25
UCB			285	+35.78%	19
BIOGEN INC.			237.19	+9.72%	31
INCYTE CORPORATION			127.74	+4.93%	23
INNOVENT BIOLOGICS, INC.			110.32	+35.69%	29
SWEDISH ORPHAN BIOVITRUM AB			500.92	+13.95%	12
BRIDGEBIO PHARMA, INC.			109.1	+59.52%	21
ALTEOGEN INC.			394,615.38	+51.78%	6
BIOMARIN PHARMACEUTICAL INC.			91.38	+41.79%	26
AXSOME THERAPEUTICS, INC.			285.42	+39.86%	21
KRYSTAL BIOTECH, INC.			385	+14.35%	8
TWIST BIOSCIENCE CORPORATION			106.25	-23.06%	12
GRIFOLS, S.A.			14.76	+52.68%	12
GAN & LEE PHARMACEUTICALS.			83	+20.5%	2
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC			98	+30.41%	8
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	-	60.94	+52.24%	1
Average			118,290.95	+24.73%	16
Weighted average by Cap.			206,937.32	+16.76%	21